AHP Use Of Testing In Redux Follow-Ups Undermines Antimonitoring Stance
Executive Summary
American Home Products' use of echocardiographic monitoring in follow-up studies in patients who received the diet drugs Pondimin (fenfluramine) or Redux (dexfenfluramine) argues for a medical monitoring program for individuals who took the drug but are still asymptomatic, plaintiffs in a N.J. class action suit contend.